Preliminary observations on the in vitro toxicity of N-butylbenzenesulfonamide: a newly discovered neurotoxin.
V R Nerurkar et al.
Annals of the New York Academy of Sciences, 679, 280-287 (1993-05-28)
K K Kim et al.
The Journal of antibiotics, 53(2), 131-136 (2000-05-11)
An antifungal bacterial strain, isolated from a greenhouse soil sample, inhibits growth of microflora nearby. It was selected for further studies of bacterial antifungal properties. This isolate was identified as a Pseudomonas sp. based on carbohydrate utilization, and other biochemical...
Sonja Schleich et al.
Planta medica, 72(9), 807-813 (2006-06-20)
Extracts from Pygeum africanum, Serenoa repens and Cucurbita pepo are used in the treatment of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The activity of the androgen receptor (AR) is known to control growth of the prostate. Here, we...
W Y Lee et al.
Veterinary and human toxicology, 37(6), 537-542 (1995-12-01)
N-butyl benzenesulfonamide (NBBS), one of the sulfonamide plasticizers, induced characteristic effects to Wistar rats after acute repeated exposures (300 mg/kg body weight, ip every 6 h). The signs were pica, staggering gait with hindlimb-paresis and splaying, teeth-grinding, self paw-biting and...
M J Strong et al.
Neurotoxicology, 12(3), 415-425 (1991-01-01)
Repeated monthly intracisternal inoculations of N-butyl benzenesulfonamide induced a chronic, slowly progressive myelopathy in young adult New Zealand white rabbits that was manifested by hyperreflexia, spasticity, hypertonia, gait impairment and altered tonic immobility responses. The neuropathological features consisted of scattered...